Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Michael D. Schwartz, Juan J. Canales, Riccardo Zucchi, Stefano Espinoza, Ilya Sukhanov & Raul R. Gainetdinov. (2018) Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases. Expert Opinion on Therapeutic Targets 22:6, pages 513-526.
Read now
Read now
Kemal Utku Yazici, Ipek Percinel Yazici & Bilal Ustundag. (2018) Vitamin D levels in children and adolescents with obsessive compulsive disorder. Nordic Journal of Psychiatry 72:3, pages 173-178.
Read now
Read now
Articles from other publishers (66)
Heliana de Barros Fernandes, Bruna da Silva Oliveira, Caroline Amaral Machado, Brener Cunha Carvalho, Eliana Cristina de Brito Toscano, Maria Carolina M. da Silva, Érica Leandro Marciano Vieira, Antônio Carlos Pinheiro de Oliveira, Antônio Lúcio Teixeira, Aline Silva de Miranda & Aristóbolo Mendes da Silva. (2024) Behavioral, neurochemical and neuroimmune features of RasGEF1b deficient mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 129, pages 110908.
Crossref
Crossref
Arezou Sayad, Bashdar Mahmud Hussen, Solat Eslami, Soudeh Ghafouri-Fard & Mohammad Taheri. (2023) Association between HOTAIR genetic variants and risk of obsessive-compulsive disorder. Biomarkers in Neuropsychiatry 9, pages 100079.
Crossref
Crossref
Steven P. Gargano, Melody G. Santos, Sydney M. Taylor & Irene Pastis. (2023) A closer look to neural pathways and psychopharmacology of obsessive compulsive disorder. Frontiers in Behavioral Neuroscience 17.
Crossref
Crossref
Lining Yin, Fang Han & Qingyun Wang. (2023) A biophysical model for dopamine modulating working memory through reward system in obsessive–compulsive disorder. Cognitive Neurodynamics.
Crossref
Crossref
David Pagliaccio, Kenneth Wengler, Katherine Durham, Martine Fontaine, Meryl Rueppel, Hannah Becker, Emily Bilek, Sarah Pieper, Caroline Risdon, Guillermo Horga, Kate D. Fitzgerald & Rachel Marsh. (2023) Probing midbrain dopamine function in pediatric obsessive-compulsive disorder via neuromelanin-sensitive magnetic resonance imaging. Molecular Psychiatry 28:7, pages 3075-3082.
Crossref
Crossref
Zheqin Li, Jian Gao, Liangjun Lin, Zifeng Zheng, Susu Yan, Weidi Wang, Dongdong Shi & Zhen Wang. (2023) Untargeted metabolomics analysis in drug-naïve patients with severe obsessive–compulsive disorder. Frontiers in Neuroscience 17.
Crossref
Crossref
Baland Jalal, Samuel R. Chamberlain & Barbara J. Sahakian. (2023) Obsessive‐compulsive disorder: Etiology, neuropathology, and cognitive dysfunction. Brain and Behavior 13:6.
Crossref
Crossref
Amir Hossein Mohammadi, Mohammad Karimian, Hamed Mirzaei & Alireza Milajerdi. (2023) Epigenetic modifications and obsessive–compulsive disorder: what do we know?. Brain Structure and Function 228:5, pages 1295-1305.
Crossref
Crossref
Abdolhakim Ghanbarzehi, Ali Sepehrinezhad, Nazanin Hashemi, Minoo Karimi & Ali Shahbazi. (2023) Disclosing common biological signatures and predicting new therapeutic targets in schizophrenia and obsessive–compulsive disorder by integrated bioinformatics analysis. BMC Psychiatry 23:1.
Crossref
Crossref
Peter J. van Roessel, Giacomo Grassi, Elias N. Aboujaoude, José M. Menchón, Michael Van Ameringen & Carolyn I. Rodríguez. (2023) Treatment-resistant OCD: Pharmacotherapies in adults. Comprehensive Psychiatry 120, pages 152352.
Crossref
Crossref
Ria Gupta, Sidharth Mehan, Swesha Chhabra, Aditi Giri & Kajal Sherawat. (2022) Role of Sonic Hedgehog Signaling Activation in the Prevention of Neurological Abnormalities Associated with Obsessive–Compulsive Disorder. Neurotoxicity Research 40:6, pages 1718-1738.
Crossref
Crossref
Jennifer Nelson, J. MacLaren Kelly, Lauren Wadsworth & Erin Maloney. (2022) Co-Occurring Obsessive-Compulsive Disorder and Panic Disorder: A Review of Their Etiology and Treatment. Journal of Cognitive Psychotherapy 36:4, pages 287-314.
Crossref
Crossref
Blanca T. M. Spee, Ronald Sladky, Joerg Fingerhut, Alice Laciny, Christoph Kraus, Sidney Carls-Diamante, Christof Brücke, Matthew Pelowski & Marco Treven. (2022) Repeating patterns: Predictive processing suggests an aesthetic learning role of the basal ganglia in repetitive stereotyped behaviors. Frontiers in Psychology 13.
Crossref
Crossref
Puyu Li, Jiayue Cheng, Qing Fan, Liangjun Lin, Shuangyi Zhou, Jian Gao, Yingying Tang, Tifei Yuan & Zhen Wang. (2022) The functional connectivity predictor of therapeutic effect of continuous theta burst stimulation on obsessive-compulsive disorder: A preliminary study. Journal of Affective Disorders 311, pages 231-238.
Crossref
Crossref
Elisa Castagnola, Elaine M. Robbins, Bingchen Wu, May Yoon Pwint, Raghav Garg, Tzahi Cohen-Karni & Xinyan Tracy Cui. (2022) Flexible Glassy Carbon Multielectrode Array for In Vivo Multisite Detection of Tonic and Phasic Dopamine Concentrations. Biosensors 12:7, pages 540.
Crossref
Crossref
Ria Gupta, Sidharth Mehan, Pranshul Sethi, Aradhana Prajapati, Abdulrahman Alshammari, Metab Alharbi, Haneen A. Al-Mazroua & Acharan S. Narula. (2022) Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive Disorder. Brain Sciences 12:3, pages 342.
Crossref
Crossref
Poonam Bharti & AngadHarshbir Singh. (2022) Hassle faced with induced mania in elderly female while treating for obsessive-compulsive symptoms. Journal of Datta Meghe Institute of Medical Sciences University 17:1, pages 129.
Crossref
Crossref
Razieh Avan, Adeleh Sahebnasagh, Javad Hashemi, Mahila Monajati, Fatemeh Faramarzi, Neil C. Henney, Fabrizio Montecucco, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2021) Update on Statin Treatment in Patients with Neuropsychiatric Disorders. Life 11:12, pages 1365.
Crossref
Crossref
Jaekyung Kim, Abhijeet S. Barath, Aaron E. Rusheen, Juan M. Rojas Cabrera, J. Blair Price, Hojin Shin, Abhinav Goyal, Jason W. Yuen, Danielle E. Jondal, Charles D. Blaha, Kendall H. Lee, Dong Pyo Jang & Yoonbae Oh. (2021)
Automatic and Reliable Quantification of Tonic Dopamine Concentrations
In Vivo
Using a Novel Probabilistic Inference Method
. ACS Omega 6:10, pages 6607-6613.
Crossref
Crossref
Gwyneth Zai. 2021. The Neurobiology and Treatment of OCD: Accelerating Progress. The Neurobiology and Treatment of OCD: Accelerating Progress
385
398
.
Juan M. Rojas Cabrera, J. Blair Price, Aaron E. Rusheen, Abhinav Goyal, Danielle Jondal, Abhijeet S. Barath, Hojin Shin, Su-Youne Chang, Kevin E. Bennet, Charles D. Blaha, Kendall H. Lee & Yoonbae Oh. (2020) Advances in neurochemical measurements: A review of biomarkers and devices for the development of closed-loop deep brain stimulation systems. Reviews in Analytical Chemistry 39:1, pages 188-199.
Crossref
Crossref
Daria Piacentino, Annalisa Maraone, Valentina Roselli, Isabella Berardelli, Massimo Biondi, Georgios D. Kotzalidis & Massimo Pasquini. (2020) Efficacy of nicotine administration on obsessions and compulsions in OCD: a systematic review. Annals of General Psychiatry 19:1.
Crossref
Crossref
Gregory Milne, Joanne P. Webster & Martin Walker. (2020) Toxoplasma gondii: An Underestimated Threat?. Trends in Parasitology 36:12, pages 959-969.
Crossref
Crossref
Farzaneh Yousefzadeh, Erfan Sahebolzamani, Arash Sadri, Amirhosein Mortezaei, Ali Aqamolaei, Seyyed Hosein Mortazavi, Mohammd Reza Shalbafan, Salomeh Ghaffari, Rosa Alikhani, Seiedeh Bentolhoda Mousavi, Sina Naderi, Ahmad Shamabadi, Shakiba Jalilevand & Shahin Akhondzadeh. (2020) 5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control. International Clinical Psychopharmacology 35:5, pages 254-262.
Crossref
Crossref
J. Blair PriceAaron E. RusheenAbhijeet S. BarathJuan M. Rojas CabreraHojin ShinSu-Youne ChangChristopher J. Kimble, Kevin E. Bennet, Charles D. BlahaKendall H. Lee & Yoonbae Oh. (2020) Clinical applications of neurochemical and electrophysiological measurements for closed-loop neurostimulation. Neurosurgical Focus 49:1, pages E6.
Crossref
Crossref
Geoffrey de Brouwer, Brian H. Harvey & De Wet Wolmarans. (2020) Naturalistic operant responses in deer mice (Peromyscus maniculatus bairdii) and its response to outcome manipulation and serotonergic intervention. Behavioural Pharmacology 31:4, pages 343-358.
Crossref
Crossref
Nurdan Kasar & Nihal Yurteri. (2020) Atomoxetine Induced Skin Picking: A Case Report. Clinical Neuropharmacology 43:2, pages 46-47.
Crossref
Crossref
C. van Staden, G. de Brouwer, T.L. Botha, K. Finger-Baier, S.J. Brand & D. Wolmarans. (2020) Dopaminergic and serotonergic modulation of social reward appraisal in zebrafish (Danio rerio) under circumstances of motivational conflict: Towards a screening test for anti-compulsive drug action. Behavioural Brain Research 379, pages 112393.
Crossref
Crossref
Baland Jalal, Richard J. McNally, Jason A. Elias, Sriramya Potluri & Vilayanur S. Ramachandran. (2020) “Fake it till You Make it”! Contaminating Rubber Hands (“Multisensory Stimulation Therapy”) to Treat Obsessive-Compulsive Disorder. Frontiers in Human Neuroscience 13.
Crossref
Crossref
David D. Kim, Alasdair M. Barr, Cynthia Lu, S. Evelyn Stewart, Randall F. White, William G. Honer & Ric M. Procyshyn. (2020) Clozapine-Associated Obsessive-Compulsive Symptoms and Their Management: A Systematic Review and Analysis of 107 Reported Cases. Psychotherapy and Psychosomatics 89:3, pages 151-160.
Crossref
Crossref
Mary Kimmel. 2020. Biomarkers of Postpartum Psychiatric Disorders. Biomarkers of Postpartum Psychiatric Disorders
111
125
.
Christie L. Burton, Csaba Barta, Danielle Cath, Daniel Geller, Odile A. van den Heuvel, Yin Yao, Valsamma Eapen, Edna Grünblatt & Gwyneth Zai. 2020. Personalized Psychiatry. Personalized Psychiatry
239
252
.
Mohammadreza Shalbafan, Farzaneh Malekpour, Borna Tadayon Najafabadi, Kiandokht Ghamari, Seyed-Ali Dastgheib, Arash Mowla, Elham Shirazi, Mehrdad Eftekhar Ardebili, Maryam Ghazizadeh-Hashemi & Shahin Akhondzadeh. (2019) Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial. Journal of Psychopharmacology 33:11, pages 1407-1414.
Crossref
Crossref
Gwyneth Zai, Csaba Barta, Danielle Cath, Valsamma Eapen, Daniel Geller & Edna Grünblatt. (2019) New insights and perspectives on the genetics of obsessive-compulsive disorder. Psychiatric Genetics 29:5, pages 142-151.
Crossref
Crossref
Tomek J. Banasikowski & Emily R. Hawken. (2019) The Bed Nucleus of the Stria Terminalis, Homeostatic Satiety, and Compulsions: What Can We Learn From Polydipsia?. Frontiers in Behavioral Neuroscience 13.
Crossref
Crossref
I. M. Sukhanov. (2019) TAAR1 AGONISTS AS A POTENTIAL TARGET IN THE THERAPY OF MENTAL DISORDERS WITH THE DEFICIT OF IMPULSIVE AND COMPULSIVE CONTROL. Toxicological Review:3, pages 51-55.
Crossref
Crossref
Sina Naderi, Heidar Faghih, Ali Aqamolaei, Seyyed Hosein Mortazavi, Amirhosein Mortezaei, Erfan Sahebolzamani, Farzin Rezaei & Shahin Akhondzadeh. (2018) Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive–compulsive disorder: A double‐blind randomized trial with placebo control. Psychiatry and Clinical Neurosciences 73:4, pages 169-174.
Crossref
Crossref
Huirong Zheng, Fujun Jia, Hongying Han, Shibin Wang, Guangquan Guo, Dongming Quan, Gang Li & Huiyan Huang. (2019) Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study. European Neuropsychopharmacology 29:3, pages 397-404.
Crossref
Crossref
Cheng Xu, Hongbao Cao & Dongbai Liu. (2018) Integrative analysis of shared genetic pathogenesis by obsessive‑compulsive and eating disorders. Molecular Medicine Reports.
Crossref
Crossref
Jesse Wood, Zoe LaPalombara & Susanne E. Ahmari. (2018) Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour. Philosophical Transactions of the Royal Society B: Biological Sciences 373:1742, pages 20170023.
Crossref
Crossref
Jonathan S. Abramowitz. (2018) Presidential Address: Are the Obsessive-Compulsive Related Disorders Related to Obsessive-Compulsive Disorder? A Critical Look at DSM-5’s New Category. Behavior Therapy 49:1, pages 1-11.
Crossref
Crossref
Swarup Mitra, McKenzie Mucha, Savanah Owen & Abel Bult-Ito. (2017) Postpartum Lactation-Mediated Behavioral Outcomes and Drug Responses in a Spontaneous Mouse Model of Obsessive–Compulsive Disorder. ACS Chemical Neuroscience 8:12, pages 2683-2697.
Crossref
Crossref
Abu Hasanat Md. Zulfiker, Saeed M. Hashimi, David A. Good, I. Darren Grice & Ming Q. Wei. (2017)
Cane Toad Skin Extract—Induced Upregulation and Increased Interaction of Serotonin 2A and D
2
Receptors via G
q/11
Signaling Pathway in CLU213 Cells
. Journal of Cellular Biochemistry 118:5, pages 979-993.
Crossref
Crossref
Irina Trofimova & Trevor W. Robbins. (2016) Temperament and arousal systems: A new synthesis of differential psychology and functional neurochemistry. Neuroscience & Biobehavioral Reviews 64, pages 382-402.
Crossref
Crossref
Firoz Kazhungil & E Mohandas. (2016) Management of obsessive-compulsive disorder comorbid with bipolar disorder. Indian Journal of Psychiatry 58:3, pages 259.
Crossref
Crossref
J. Bernardo Barahona-Corrêa, Marta Camacho, Pedro Castro-Rodrigues, Rui Costa & Albino J. Oliveira-Maia. (2015) From Thought to Action: How the Interplay Between Neuroscience and Phenomenology Changed Our Understanding of Obsessive-Compulsive Disorder. Frontiers in Psychology 6.
Crossref
Crossref
Sandra M Meier, Liselotte Petersen, Diana E Schendel, Manuel Mattheisen, Preben B Mortensen & Ole Mors. (2015) Obsessive-Compulsive Disorder and Autism Spectrum Disorders: Longitudinal and Offspring Risk. PLOS ONE 10:11, pages e0141703.
Crossref
Crossref
Sara Marconi, Fabiano Scarlatti, Giovanni Rizzo, Elena Antelmi, Marco Innamorati, Maurizio Pompili, Roberto Brugnoli, Martino Belvederi Murri, Mario Amore & Federica Provini. (2015) Is nocturnal eating in restless legs syndrome linked to a specific psychopathological profile? A pilot study. Journal of Neural Transmission 122:11, pages 1563-1571.
Crossref
Crossref
Anders Lillevik Thorsen, Odile A. van den Heuvel, Bjarne Hansen & Gerd Kvale. (2015) Neuroimaging of psychotherapy for obsessive–compulsive disorder: A systematic review. Psychiatry Research: Neuroimaging 233:3, pages 306-313.
Crossref
Crossref
Christine Lochner, Nathaniel McGregor, Sian Hemmings, Brian H. Harvey, Elsie Breet, Sonja Swanevelder & Dan J. Stein. (2015) Symmetry symptoms in obsessive-compulsive disorder: clinical and genetic correlates. Revista Brasileira de Psiquiatria 38:1, pages 17-23.
Crossref
Crossref
Jonathan S. AbramowitzRyan J. Jacoby. (2015) Obsessive-Compulsive and Related Disorders: A Critical Review of the New Diagnostic Class. Annual Review of Clinical Psychology 11:1, pages 165-186.
Crossref
Crossref
Dursun Karaman, İbrahim Durukan & Murat Erdem. (2014) Çocukluk Çağı Başlangıçlı Obsesif Kompulsif Bozukluk. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry 3:2, pages 278-295.
Crossref
Crossref
Trehani M. Fonseka, Margaret A. Richter & Daniel J. Müller. (2014) Second Generation Antipsychotic-Induced Obsessive-Compulsive Symptoms in Schizophrenia: A Review of the Experimental Literature. Current Psychiatry Reports 16:11.
Crossref
Crossref
Silvia Brem, Edna Grünblatt, Renate Drechsler, Peter Riederer & Susanne Walitza. (2014) The neurobiological link between OCD and ADHD. ADHD Attention Deficit and Hyperactivity Disorders 6:3, pages 175-202.
Crossref
Crossref
Gwyneth Zai, Eva J Brandl, Daniel J Müller, Margaret A Richter & James L Kennedy. (2014) Pharmacogenetics of antidepressant treatment in obsessive–compulsive disorder: an update and implications for clinicians. Pharmacogenomics 15:8, pages 1147-1157.
Crossref
Crossref
Thibaut Sesia, Brandon Bizup & Anthony A. Grace. (2013) Nucleus accumbens high-frequency stimulation selectively impacts nigrostriatal dopaminergic neurons. The International Journal of Neuropsychopharmacology 17:03, pages 421-427.
Crossref
Crossref
Thibaut Sesia, Brandon Bizup & Anthony A. Grace. (2013) Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity. International Journal of Neuropsychopharmacology 16:6, pages 1295-1307.
Crossref
Crossref
Priya Gopalan, Pierre N. Azzam & Robert Hudak. (2013) Pramipexole-Induced Obsessive-Compulsive Symptoms in a Patient with Parkinson's Disease and Disgust Sensitivity. Psychosomatics 54:3, pages 286-289.
Crossref
Crossref
Joan Gunther, Yingfang Tian, Boryana Stamova, Lisa Lit, Blythe Corbett, Brad Ander, Xinhua Zhan, Glen Jickling, Netty Bos-Veneman, Da Liu, Pieter Hoekstra & Frank Sharp. (2012) Catecholamine-related gene expression in blood correlates with tic severity in tourette syndrome. Psychiatry Research 200:2-3, pages 593-601.
Crossref
Crossref
Bhanu PS Kaurav, Manish M Wanjari, Amol Chandekar, Nagendra Singh Chauhan & Neeraj Upmanyu. (2012) Influence of Withania somnifera on obsessive compulsive disorder in mice. Asian Pacific Journal of Tropical Medicine 5:5, pages 380-384.
Crossref
Crossref
Eric H. Decloedt & Dan J. Stein. 2012. Obsessive‐Compulsive Disorder. Obsessive‐Compulsive Disorder
31
57
.
Christine Winter. 2012. Deep Brain Stimulation. Deep Brain Stimulation
61
70
.
Stefan G. Hofmann, Cassidy A. Gutner & Anu Asnaani. 2012. Exposure Therapy. Exposure Therapy
89
110
.
Yuan Wang, Carol A. Mathews, Ying Li, Zhiguang Lin & Zeping Xiao. (2011) Brain-derived neurotrophic factor (BDNF) plasma levels in drug-naïve OCD patients are lower than those in healthy people, but are not lower than those in drug-treated OCD patients. Journal of Affective Disorders 133:1-2, pages 305-310.
Crossref
Crossref
Stefan G. Hofmann, Jasper A.J. Smits, Anu Asnaani, Cassidy A. Gutner & Michael W. Otto. (2011) Cognitive enhancers for anxiety disorders. Pharmacology Biochemistry and Behavior 99:2, pages 275-284.
Crossref
Crossref
Mehmet Ak, Suheyla Dogan Bulut, Ali Bozkurt & Aytekin Ozsahin. (2011) Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study. Advances in Therapy 28:4, pages 341-348.
Crossref
Crossref